Posting fresh info about MS, for people with MS and their supporters


FDA delays ruling on Acorda’s MS drug until 1/2010


October 22, 2009 6:38 AM ET

HAWTHORNE, N.Y. (AP) – Acorda Therapeutics Inc. said Thursday the Food and Drug Administration delayed a ruling on its multiple sclerosis drug candidate Fampridine-SR by three months.

The agency was due to make a decision by Thursday, but the ruling is now due by Jan. 22, 2010.

Acorda said the FDA extended its review because it recently submitted new information on its risk evaluation strategy for the drug.

Acorda sent in the additional information following a meeting with an FDA panel on Oct. 14. The panel recommended that Fampridine-SR receive FDA approval.

View full post here: http://news.moneycentral.msn.com/provider/providerarticle.aspx?feed=AP&date=20091022&id=10582834


SPEAK / ADD YOUR COMMENT
Comments are moderated.

XHTML: You can use these tags: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

Return to Top

Inside

FRESH / LATEST POSTS

TAG / CLOUD